These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1017 related articles for article (PubMed ID: 17962485)
1. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. You JJ; Yang CH; Huang JS; Chen MS; Yang CM Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485 [TBL] [Abstract][Full Text] [Related]
2. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432 [TBL] [Abstract][Full Text] [Related]
3. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708 [TBL] [Abstract][Full Text] [Related]
4. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy. You JJ; Yang CH; Chen MS; Yang CM Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885 [TBL] [Abstract][Full Text] [Related]
5. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha. Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo. Kwon YS; Hong HS; Kim JC; Shin JS; Son Y Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269 [TBL] [Abstract][Full Text] [Related]
7. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666 [TBL] [Abstract][Full Text] [Related]
8. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model. Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957 [TBL] [Abstract][Full Text] [Related]
9. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis. Fang IM; Lin CP; Yang CM; Chen MS; Yang CH Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495 [TBL] [Abstract][Full Text] [Related]
10. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets in vitro. Kanayama S; Nishida K; Yamato M; Hayashi R; Sugiyama H; Soma T; Maeda N; Okano T; Tano Y Exp Eye Res; 2007 Dec; 85(6):772-81. PubMed ID: 17904552 [TBL] [Abstract][Full Text] [Related]
11. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858 [TBL] [Abstract][Full Text] [Related]
13. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture. Castellon R; Caballero S; Hamdi HK; Atilano SR; Aoki AM; Tarnuzzer RW; Kenney MC; Grant MB; Ljubimov AV Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2758-66. PubMed ID: 12147613 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a). Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999 [TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Ma X; Ottino P; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102 [TBL] [Abstract][Full Text] [Related]
16. Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina. Stitt AW; Graham D; Gardiner TA Mol Vis; 2004 Jun; 10():432-8. PubMed ID: 15235573 [TBL] [Abstract][Full Text] [Related]
17. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt. Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373 [TBL] [Abstract][Full Text] [Related]
18. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578 [TBL] [Abstract][Full Text] [Related]
19. Remodeling retinal neovascularization by ALK1 gene transfection in vitro. Li B; Yin W; Hong X; Shi Y; Wang HS; Lin SF; Tang SB Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4553-60. PubMed ID: 18829861 [TBL] [Abstract][Full Text] [Related]
20. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice. Fujita S; Saika S; Kao WW; Fujita K; Miyamoto T; Ikeda K; Nakajima Y; Ohnishi Y Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3051-5. PubMed ID: 17591872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]